Early maternal care restores LINE-1 methylation and enhances neurodevelopment in preterm infants

Camilla Fontana1, Federica Marasca2, Livia Provitera3

  • 1Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

BMC Medicine
|February 5, 2021
PubMed

Insights

Early intervention for preterm infants can restore LINE-1 (L1) methylation, improving neurodevelopment. This study highlights L1 activity as a novel predictor for prematurity-related outcomes.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Developmental Biology

Background:

  • Preterm birth impacts 9-11% of newborns, causing neurodevelopmental disabilities.
  • Retrotransposons like LINE-1 (L1) contribute to genomic mosaicism and are implicated in neurological disorders.
  • Early life experiences can modulate L1 activity, particularly in neuronal cells.

Purpose of the Study:

  • To investigate the impact of early intervention on L1 methylation in preterm infants.
  • To explore the relationship between L1 methylation and neurodevelopmental outcomes.
  • To examine L1 epigenetic regulation in the developing mouse brain.

Main Methods:

  • Randomized controlled trial comparing standard care with early intervention for very preterm infants.
  • Measurement of L1 promoter methylation at birth and hospital discharge.
  • Neurodevelopmental assessment at 12 and 36 months using Griffiths Scales.
  • Analysis of L1 methylation and copy number variations (CNVs) in mouse brain tissues.

Main Results:

  • Preterm infants exhibited hypomethylation of the L1 promoter at birth.
  • Early intervention normalized L1 methylation levels, similar to healthy newborns.
  • Intervention ameliorated childhood neurodevelopmental outcomes.
  • L1 activity is dynamically regulated in the perinatal mouse brain, indicating a critical window for epigenetic programming.

Conclusions:

  • Early intervention can positively impact L1 methylation and neurodevelopment in preterm infants.
  • L1 methylation serves as a potential molecular marker for predicting neurodevelopmental outcomes in prematurity.
  • This research opens avenues for novel molecular strategies targeting L1 activity to improve infant neurodevelopment.
Abstract